These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 24827829)
41. An overexpression of fibroblast growth factor (FGF) and FGF receptor 4 in a severe clinical phenotype of facioscapulohumeral muscular dystrophy. Saito A; Higuchi I; Nakagawa M; Saito M; Uchida Y; Inose M; Kasai T; Niiyama T; Fukunaga H; Arimura K; Osame M Muscle Nerve; 2000 Apr; 23(4):490-7. PubMed ID: 10716758 [TBL] [Abstract][Full Text] [Related]
42. Facioscapulohumeral muscular dystrophy presenting isolated monomelic lower limb atrophy. Report of two patients with and without 4q35 rearrangement. Uncini A; Galluzzi G; Di Muzio A; De Angelis MV; Ricci E; Scoppetta C; Servidei S Neuromuscul Disord; 2002 Nov; 12(9):874-7. PubMed ID: 12398841 [TBL] [Abstract][Full Text] [Related]
43. Drug treatment for facioscapulohumeral muscular dystrophy. Rose MR; Tawil R Cochrane Database Syst Rev; 2004; 2004(2):CD002276. PubMed ID: 15106171 [TBL] [Abstract][Full Text] [Related]
44. Chronic Myopathy Associated With Anti-Signal Recognition Particle Antibodies Can Be Misdiagnosed As Facioscapulohumeral Muscular Dystrophy. Ikeda K; Mori-Yoshimura M; Yamamoto T; Sonoo M; Suzuki S; Kondo Y; Nakamura H; Mitsuhashi K; Maeda MH; Shimizu J; Hayashi YK; Nishino I; Oya Y; Murata M J Clin Neuromuscul Dis; 2016 Jun; 17(4):197-206. PubMed ID: 27224434 [TBL] [Abstract][Full Text] [Related]
45. Muscle pathology from stochastic low level DUX4 expression in an FSHD mouse model. Bosnakovski D; Chan SSK; Recht OO; Hartweck LM; Gustafson CJ; Athman LL; Lowe DA; Kyba M Nat Commun; 2017 Sep; 8(1):550. PubMed ID: 28916757 [TBL] [Abstract][Full Text] [Related]
46. Facioscapulohumeral muscular dystrophy presenting with hypertrophic cardiomyopathy: a case study. Tsuji M; Kinoshita M; Imai Y; Kawamoto M; Kohara N Neuromuscul Disord; 2009 Feb; 19(2):140-2. PubMed ID: 19147353 [TBL] [Abstract][Full Text] [Related]
59. Respiratory function in facioscapulohumeral muscular dystrophy 1. Wohlgemuth M; Horlings CGC; van der Kooi EL; Gilhuis HJ; Hendriks JCM; van der Maarel SM; van Engelen BGM; Heijdra YF; Padberg GW Neuromuscul Disord; 2017 Jun; 27(6):526-530. PubMed ID: 28416348 [TBL] [Abstract][Full Text] [Related]
60. A Great Athlete with Muscular Weakness. Bourguiba R; Masingue M; Marc PJ; Lenglet T; Bachmeyer C Am J Med; 2021 Feb; 134(2):e109-e110. PubMed ID: 32835688 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]